Matches in Wikidata for { <http://www.wikidata.org/entity/Q97559531> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q97559531 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97559531 description "scientific article published on 06 July 2020" @default.
- Q97559531 description "wetenschappelijk artikel" @default.
- Q97559531 description "наукова стаття, опублікована 6 липня 2020" @default.
- Q97559531 name "Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study" @default.
- Q97559531 name "Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study" @default.
- Q97559531 type Item @default.
- Q97559531 label "Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study" @default.
- Q97559531 label "Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study" @default.
- Q97559531 prefLabel "Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study" @default.
- Q97559531 prefLabel "Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study" @default.
- Q97559531 P1433 Q97559531-38AC7E12-4ABC-48C2-95B0-C60D8DEC18CA @default.
- Q97559531 P1476 Q97559531-ABA745B9-7CAB-4947-B578-7B079A1ECE9E @default.
- Q97559531 P2093 Q97559531-15CC4EC7-5083-4C95-949C-670F0E7B46A8 @default.
- Q97559531 P2093 Q97559531-2ABE30EB-9442-456C-B80B-43C62A6F2D5B @default.
- Q97559531 P2093 Q97559531-7EE4C335-AA7B-4B5E-BFA4-FABCC19D0321 @default.
- Q97559531 P2093 Q97559531-B02DA91F-8EA6-4F2D-A6F7-E1052F5D2156 @default.
- Q97559531 P2093 Q97559531-B2638C81-AC5B-41F1-A8F5-4D67FEEB56BF @default.
- Q97559531 P2093 Q97559531-C64D0313-621F-4F5A-AD9D-2A8C7BB5728E @default.
- Q97559531 P304 Q97559531-6DD67897-3327-4A67-A0ED-53A04D93B781 @default.
- Q97559531 P31 Q97559531-6DAA8C2F-78A8-404F-92CD-01BA9F506B2E @default.
- Q97559531 P356 Q97559531-579EEEE7-2E32-46CF-BB6D-CEF47F45D3BD @default.
- Q97559531 P478 Q97559531-C94C4391-1D32-4E75-BA84-CB154AEC5847 @default.
- Q97559531 P577 Q97559531-ECEDCD76-7C1D-4166-BEF4-C8407EA76473 @default.
- Q97559531 P698 Q97559531-C25875B8-8020-43B8-9AA1-9B7F28B22A7E @default.
- Q97559531 P921 Q97559531-847958F7-A26A-43B6-8608-6929BB1D7237 @default.
- Q97559531 P356 J.JNS.2020.117012 @default.
- Q97559531 P698 32673884 @default.
- Q97559531 P1433 Q6296168 @default.
- Q97559531 P1476 "Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study" @default.
- Q97559531 P2093 "Akihiko Yamamoto" @default.
- Q97559531 P2093 "ME2125-4 Study Group" @default.
- Q97559531 P2093 "Masahiro Nomoto" @default.
- Q97559531 P2093 "Nobutaka Hattori" @default.
- Q97559531 P2093 "Yoshio Tsuboi" @default.
- Q97559531 P2093 "Yuji Sasagawa" @default.
- Q97559531 P304 "117012" @default.
- Q97559531 P31 Q13442814 @default.
- Q97559531 P356 "10.1016/J.JNS.2020.117012" @default.
- Q97559531 P478 "416" @default.
- Q97559531 P577 "2020-07-06T00:00:00Z" @default.
- Q97559531 P698 "32673884" @default.
- Q97559531 P921 Q11085 @default.